MiNK Therapeutics stockholders re-elect Garo Armen, Barbara Ryan, John Holcomb as directors; ratify KPMG

MiNK Therapeutics, Inc.

Quorum of 3,277,906 shares (65.79% of outstanding) present at annual meeting.
All three Class II director nominees elected: Garo Armen (2,363,360 for), Barbara Ryan (2,362,760 for), John Holcomb (2,381,491 for).
Ratification of KPMG as independent auditor for 2026 approved: 3,249,124 for, 26,560 against, 2,222 abstain.
Broker non-votes of 881,648 on director election; no broker non-votes on auditor ratification.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.